Replies to post #102758 on Sunshine Biopharma Inc (SBFM)

[HoldWhatDoor]

You realize Slilaty was the CEO of Advanomics

[HoldWhatDoor]

He also is credited with inventing adva-27a

https://uspto.report/patent/grant/10272065

[HoldWhatDoor]

That $17 million was reduced to $618k, and then they increased their authorized capital and issued 321+ million to pay for it.

"Effective December 28, 2015, we entered into amendments (the “Amendments”) of these Purchase Agreements pursuant to which the total purchase price was reduced from $17,142,499 to $618,810, the book value of this intellectual property on the financial statements of Advanomics.  Further, the Amendments provided for automatic conversion of the promissory notes representing the new purchase price into an aggregate of 321,305,415 shares of our Common Stock once we increase our authorized capital such that these shares can be issued.  In July 2016 we increased our authorized capital and issued the 321,305,415 Common shares to Advanomics thereby completing all aspects of the patent purchase arrangements and securing direct ownership of all worldwide patents and rights pertaining to Adva-27a."

Top of page 8 from the Form 10K linked here:
https://www.sec.gov/Archives/edgar/data/1402328/000165495417003365/sbfm_10k.htm